Open AccessBasic principles for the management of neurological patients during the COVID-19 pandemic
Author(s) -
Svetlana Kopishinskaia,
Н О Жаринова,
И. А. Величко,
Н. Г. Жукова,
В. В. Буцев,
Иван Викторович Коробейников,
А. А. Гасанова,
Ani Arakelian,
О. В. Петручик,
А. Н. Паюдис
Publication year - 2020
Publication title -
nervno-myšečnye bolezni
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.139
H-Index - 3
eISSN - 2413-0443
pISSN - 2222-8721
DOI - 10.17650/2222-8721-2020-10-1-31-42
Subject(s) - pandemic , medicine , multiple sclerosis , disease , stroke (engine) , epilepsy , neurology , covid-19 , intensive care medicine , disease management , amyotrophic lateral sclerosis , parkinson's disease , immunology , infectious disease (medical specialty) , pathology , psychiatry , mechanical engineering , engineering
In a COVID-19 pandemic, a neurologist needs to be able to assess the risks of virus infection in patients with individual neurological diseases. The review presents categories of risk groups from the Association of British Neurologists for neuromuscular diseases, multiple sclerosis and other autoimmune diseases of the central nervous system, stroke, epilepsy and Parkinson’s disease. The risk of infection and the management of patients with neuromuscular diseases are analyzed in detail. The use of multiple sclerosis disease modifying drugs, the treatment of stroke patients are discussed. The data from the international guidelines for the management of patients with epilepsy and Parkinson’s disease are presented.